1 Min Read
Dec 13 (Reuters) - Interpace Diagnostics Group Inc :
* Interpace Diagnostics Group - has launched multi-site study to provide further evidence of clinical utility of thygenx/thyramir tests Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.